Lantheus Holdings Inc 's ability to collect accounts receivable sequentially worsen to 4.39, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Average collection period, for Lantheus Holdings Inc 's accounts receivable remained unchanged at 83 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 200 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1523, from overall ranking in the first quarter 2026 at 2537.

What is Receivable Turnover Ratio?
What is Lantheus Holdings Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LNTH Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	4.85 %	1.98 %	11.64 %	6.69 %	-9.59 %
Y / Y Revenue Change	2.69 %	1.13 %	3.92 %	1.39 %	-4 %
Receivable Turnover Ratio (TTM)	4.39	4.41	4.42	4.49	4.55
LNTH's Total Ranking	# 1523	# 2537	# 2662	# 1366	# 2494
Accounts Receivable average collection period days	83	83	83	81	80
Seq. Receivable Change	-0.78 %	-0.83 %	2.07 %	4.4 %	-3.49 %
Seq. Revenue Change	2.99 %	-7.36 %	6.13 %	1.42 %	1.43 %

Receivable Turnover Company Ranking
Within:	No.
In Vitro & In Vivo Diagnostic Substances Industry	# 5
Healthcare Sector	# 201
Overall Market	# 1523

Receivable Turnover Ratio Statistics
High	Average	Low
1.24	0.84	0.39
(Jun 30 2017)		(Mar 31 2021)

LNTH Company Profile • Back to LNTH Efficiency Comparisons • Compare LNTH Receivables Turnover Ratio to its Competitors

Financial Statements
Lantheus Holdings Inc 's Accounts Receivable	$ 353 Millions	Visit LNTH's Balance sheet
Lantheus Holdings Inc 's Sales TTM	$ 1,555 Millions	Visit LNTH's Income Statement
Sources of LNTH's Revenues		Visit LNTH's Sales by Geography

Other Accounts Receivable Turnover Ratios
In Vitro & In Vivo Diagnostic Substances Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
LNTH's Receivable Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
LNTH's Growth Rates	LNTH's Roa	LNTH's Inventory Turnover Ratio	LNTH's Dividend Comparisons
LNTH's Profitability Ratios	LNTH's Roi	LNTH's Asset Turnover Ratio	LNTH's Dividend Growth
LNTH's Valuation Ratios	LNTH's Roe	LNTH's Financial Strength Ratios	LNTH's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Milestone Scientific Inc	11.82	$ 8.855 Millions	$ 0.749 Millions
Teladoc Health Inc	11.74	$ 2,489.480 Millions	$ 212.023 Millions
Marpai Inc	11.71	$ 16.635 Millions	$ 1.420 Millions
Catheter Precision Inc	11.62	$ 1.915 Millions	$ 0.165 Millions
Icu Medical Inc	11.42	$ 2,159.998 Millions	$ 189.166 Millions
National Healthcare Corp	11.40	$ 1,559.020 Millions	$ 136.723 Millions
Nrc Health	11.35	$ 139.996 Millions	$ 12.337 Millions
Picard Medical Inc	11.34	$ 5.983 Millions	$ 0.528 Millions
Innoviva Inc	11.22	$ 420.630 Millions	$ 37.491 Millions
Veracyte Inc	11.07	$ 544.735 Millions	$ 49.194 Millions
International Stem Cell Corporation	10.91	$ 9.514 Millions	$ 0.872 Millions
Caredx Inc	10.81	$ 458.089 Millions	$ 42.359 Millions
Premier Air Charter Holdings Inc	10.66	$ 31.562 Millions	$ 2.961 Millions
C4 Therapeutics Inc	10.65	$ 35.039 Millions	$ 3.290 Millions
Kymera Therapeutics Inc	10.50	$ 105.000 Millions	$ 10.000 Millions
Lifeloc Technologies Inc	10.48	$ 9.269 Millions	$ 0.884 Millions
Irhythm Holdings Inc	10.42	$ 825.702 Millions	$ 79.250 Millions
Immucell Corporation	10.29	$ 29.777 Millions	$ 2.893 Millions
Addus Homecare Corp	10.23	$ 1,475.610 Millions	$ 144.195 Millions
Dariohealth Corp	10.23	$ 21.196 Millions	$ 2.072 Millions
Biodesix Inc	10.21	$ 102.939 Millions	$ 10.081 Millions
Viemed Healthcare Inc	10.18	$ 301.606 Millions	$ 29.637 Millions
Radnet Inc	10.11	$ 2,268.932 Millions	$ 224.447 Millions
Kestra Medical Technologies Ltd	10.00	$ 105.939 Millions	$ 10.590 Millions
United Therapeutics Corporation	9.93	$ 3,154.500 Millions	$ 317.550 Millions
Utah Medical Products Inc	9.88	$ 35.679 Millions	$ 3.612 Millions
Lensar Inc	9.75	$ 60.264 Millions	$ 6.184 Millions
Biolife Solutions Inc	9.67	$ 102.718 Millions	$ 10.626 Millions
Encompass Health Corporation	9.57	$ 6,206.100 Millions	$ 648.325 Millions
The Oncology Institute Inc	9.57	$ 587.244 Millions	$ 61.364 Millions

Date modified: 2026-09-08T01:19:55+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.